Shruti Shiromwar

• Teaching Interests: Anatomy, Physiology, Pharmacology, Toxicology, and Clinical Pharmacy
• Research Interests: Pre-clinical research, clinical research and outcomes, pharmacovigilance, and clinical data management.
• Research Profile:

  Shruti S. Shiromwar is a Clinical Pharmacy researcher with nearly 10 years of academic and research experience, including significant international exposure in Malaysia and the Middle East. Her work spans pre-clinical and clinical pharmacology, with 21 peer-reviewed publications and many book chapters in reputed publishers.

  • Google Scholar, Scopus, ORCID

Professional Memberships:

• Registered Pharmacist, Maharashtra State Pharmacy Council, Mumbai. No.82400
• National Committee of Bio Ethics (NCEB) certification, Hosted by King Abdulaziz City for Science & Technology (KACST), Kingdom of Saudi Arabia, No: 1001463.
• Registered member of the Saudi Heart Association, Registration ID: 10792245

Recent Publications:

1. Alqahtani, Y. S., Chidrawar, V. R., Shiromwar, S., Singh, S., Maheshwari, R., Chitme, H., Chilamakuru, N. B., Mohite, P., Aljameeli, A. M., & Khateeb, M. M. "A multi-modal approach to investigate Desmodium gangeticum's influence on stress-induced male infertility: In vivo, in vitro, and in silico assessments” (2024) Biomedicine & pharmacotherapy, 173, 116358. IF: 7.5, Elsevier
2. Divya, K Thanmaya, Chidrawar, Vijay R* Bhupalam, Pradeep Kumar; Shiromwar, Shruti, Aljameeli, Ahmed M, Vyshnavi, G.; Reddama, I. Sai, Boreddy, Vishali”. Assessment of knowledge and attitude of cervical cancer among the youths in the Rayalaseema region of Andhra Pradesh – India” Journal of Education and Health Promotion 13(1):73, February 2024. (ESCI, IF: 1.4)
3. Shruti Subhash Shiromwar, Vijay R. Chidrawar, Sudarshan Singh, Havagiray R. Chitme, Rahul Maheshwari & Shabnam Sultana "Multi-faceted Anti-obesity Effects of N-Methyl-D-Aspartate (NMDA) Receptor Modulators: Central-Peripheral Crosstalk.” Journal of Molecular Neuroscience 74, 13 (2024). https://doi.org/10.1007/s12031-023-02178-z. [IF:3 Springer Nature]
4. Amer Hayat Khan, Basavraj Sayabanna Nagoba, Shruti Subhash Shiromwar*. (2023) A critical review of risk factors influencing the prevalence of extensive drug-resistant tuberculosis in India. The International Journal of Mycobacteriology 12 (4), 372-379.
5. S S Shiromwar, A H Khan, V Chidrawar (2023) "A systemic review on extensive drug resistance tuberculosis from 2009-2020: Special emphasis on Treatment Outcomes (2023). Official Journal of Spanish Society of Chemotherapy” Rev Esp Quimioter. doi: 10.37201/req/029.2022. (Sociedad Espanola Quimioterapia, IF: 2.52)